Vascular cognitive impairment and dementia drug-development pipeline 2025.
Saved in:
| Title: | Vascular cognitive impairment and dementia drug-development pipeline 2025. |
|---|---|
| Authors: | Xu Y; Centre for Healthy Brain Aging (CHeBA), Discipline of Psychiatry and Mental Health, School of Clinical Medicine Faculty of Medicine and Health, UNSW Sydney Australia., Sachdev PS; Centre for Healthy Brain Aging (CHeBA), Discipline of Psychiatry and Mental Health, School of Clinical Medicine Faculty of Medicine and Health, UNSW Sydney Australia.; Neuropsychiatric Institute the Prince of Wales Hospital Sydney NSW Australia., Lennon MJ; Centre for Healthy Brain Aging (CHeBA), Discipline of Psychiatry and Mental Health, School of Clinical Medicine Faculty of Medicine and Health, UNSW Sydney Australia.; Neuropsychiatric Institute the Prince of Wales Hospital Sydney NSW Australia.; Royal North Shore Hospital North Shore Local Health District Sydney NSW Australia. |
| Source: | Alzheimer's & dementia (New York, N. Y.) [Alzheimers Dement (N Y)] 2026 May 11; Vol. 12, pp. e70263. Date of Electronic Publication: 2026 May 11 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Wiley on behalf of the Alzheimer's Association Country of Publication: United States NLM ID: 101650118 Publication Model: eCollection Cited Medium: Internet ISSN: 2352-8737 (Electronic) Linking ISSN: 23528737 NLM ISO Abbreviation: Alzheimers Dement (N Y) Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2352-8737 |
|---|---|
| DOI: | 10.1002/trc2.70263 |
